-
公开(公告)号：US20140343011A1
公开(公告)日：2014-11-20
申请号：US14006771
申请日：2012-03-23
IPC分类号： A61K31/728 , A23L2/38 , A23L2/52 , A61K45/06
CPC分类号： A61K31/737 , A23L2/38 , A23L2/52 , A23V2002/00 , A61K9/0034 , A61K31/728 , A61K45/06 , C08B37/0072 , A61K2300/00
摘要： Described herein are methods for treating or preventing urological inflammation in a subject comprising administering to the subject an effective amount of a compound comprising a. a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and at least one primary C-6 hydroxyl position of an N-acetyl-glucosamine residue comprising an alkyl group or fluoroalkyl group; b. a partially or fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof, or a combination thereof.
摘要翻译： 本文描述了治疗或预防受试者泌尿系炎症的方法，包括向受试者施用有效量的包含a。 修饰的透明质酸或其药学上可接受的盐或酯，其中所述透明质酸或其药学上可接受的盐或酯包含至少一个硫酸根基团和包含烷基的N-乙酰基 - 葡糖胺残基的至少一个C 6羟基位置 或氟烷基; b。 部分或完全硫酸化的透明质酸或其药学上可接受的盐或酯，或其组合。
-
公开(公告)号：US09522162B2
公开(公告)日：2016-12-20
申请号：US14006771
申请日：2012-03-23
IPC分类号： A61K31/728 , A61K31/737 , C08B37/08 , A61K45/06 , A23L2/38 , A23L2/52 , A61K9/00
CPC分类号： A61K31/737 , A23L2/38 , A23L2/52 , A23V2002/00 , A61K9/0034 , A61K31/728 , A61K45/06 , C08B37/0072 , A61K2300/00
摘要： Described herein are methods for treating or preventing urological inflammation in a subject comprising administering to the subject an effective amount of a compound comprising a. a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and at least one primary C-6 hydroxyl position of an N-acetyl-glucosamine residue comprising an alkyl group or fluoroalkyl group; b. a partially or fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof, or a combination thereof.
摘要翻译： 本文描述了治疗或预防受试者泌尿系炎症的方法，包括向受试者施用有效量的包含a。 修饰的透明质酸或其药学上可接受的盐或酯，其中所述透明质酸或其药学上可接受的盐或酯包含至少一个硫酸根基团和包含烷基的N-乙酰基 - 葡糖胺残基的至少一个C 6羟基位置 或氟烷基; b。 部分或完全硫酸化的透明质酸或其药学上可接受的盐或酯，或其组合。
-
公开(公告)号：US08343942B2
公开(公告)日：2013-01-01
申请号：US13069860
申请日：2011-03-23
IPC分类号： A61K31/728 , A61K9/00 , C08B37/08 , A61P27/02 , A61P27/04
CPC分类号： A61K31/737 , A61K45/06 , A61K2300/00
摘要： Described herein are methods for treating interstitial cystitis in a subject comprising administering to the subject an effective amount of a compound which is a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with an unsubstituted alkyl group or fluoroalkyl group.
摘要翻译： 本文描述了用于治疗受试者间质性膀胱炎的方法，包括向受试者施用有效量的作为修饰的透明质酸或其药学上可接受的盐或酯的化合物，其中所述透明质酸或其药学上可接受的盐或酯包含至少一种 硫酸基和至少一个N-乙酰基 - 葡糖胺残基的C 1 -C 6羟基质子被未取代的烷基或氟代烷基取代。
-
公开(公告)号：US20120021968A1
公开(公告)日：2012-01-26
申请号：US13069860
申请日：2011-03-23
IPC分类号： A61K38/02 , A61K31/7088 , G01N33/573 , A61P29/00 , A61P13/08 , A61P13/10 , A61P15/02 , A61P15/00 , A61P13/00 , A61K31/728 , A61P13/12
CPC分类号： A61K31/737 , A61K45/06 , A61K2300/00
摘要： Described herein are methods for treating or preventing urological inflammation in a subject comprising administering to the subject an effective amount of a compound comprising a. a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and at least one primary C-6 hydroxyl position of an N-acetyl-glucosamine residue comprising an alkyl group or fluoroalkyl group; b. a partially or fully sulfated hyaluronan or the pharmaceutically acceptable salt or ester thereof, or a combination thereof.
摘要翻译： 本文描述了治疗或预防受试者泌尿系炎症的方法，包括向受试者施用有效量的包含a。 修饰的透明质酸或其药学上可接受的盐或酯，其中所述透明质酸或其药学上可接受的盐或酯包含至少一个硫酸根基团和包含烷基的N-乙酰基 - 葡糖胺残基的至少一个C 6羟基位置 或氟烷基; b。 部分或完全硫酸化的透明质酸或其药学上可接受的盐或酯，或其组合。
-
5.发明申请COMPOUNDS WITH TRPV4 ACTIVITY, COMPOSITIONS AND ASSOCIATED METHODS THEREOF 审中-公开具有TRPV4活性的化合物，组合物及其相关方法公开(公告)号：US20130303539A1
公开(公告)日：2013-11-14
申请号：US13841790
申请日：2013-03-15
申请人： David Krizaj , Glenn D. Prestwich , Peter Barabas , Yong Xu , Daniel Ryskamp
发明人： David Krizaj , Glenn D. Prestwich , Peter Barabas , Yong Xu , Daniel Ryskamp
IPC分类号： C07D207/34 , A61K45/06 , A61K31/5377
CPC分类号： A61K31/5377 , A61K45/06 , C07D207/34 , C07D209/42 , C07D471/04
摘要： Compounds, compositions and methods useful for treating ocular diseases are provided. In particular, antagonists of TRPV4, their synthesis, pharmaceutical compositions thereof and methods of treating ocular diseases such as glaucoma, are disclosed.
摘要翻译： 提供了可用于治疗眼部疾病的化合物，组合物和方法。 特别地，公开了TRPV4的拮抗剂，它们的合成，其药物组合物和治疗眼部疾病如青光眼的方法。
-
公开(公告)号：US20130172985A1
公开(公告)日：2013-07-04
申请号：US13522032
申请日：2011-01-13
IPC分类号： C07K14/435 , A61F2/06 , A61N5/06
CPC分类号： C07K14/435 , A61F2/06 , A61K41/0042 , A61L27/222 , A61L27/38 , A61L27/48 , A61L27/52 , A61N5/062 , C07K14/78 , C08H1/06 , C08J3/246 , C08J2305/08 , C08J2389/00 , C08K5/0025 , C08L89/06 , C08L2312/00 , C08L89/00
摘要： Described herein are modified gelatins or the pharmaceutically-acceptable salts or esters thereof comprising at least one actinically crosslinkable group covalently bonded to gelatin. The modified gelatins are useful in producing composites that ultimately can be used to produce three-dimensional engineered biological constructs. The composites are the polymerization product between the modified gelatin and at least one actinically crosslinkable macromolecule. Methods for making the modified gelatins are also described herein.
摘要翻译： 本文描述的是修饰明胶或其药学上可接受的盐或酯，其包含共价键合到明胶上的至少一种可光化交联的基团。 修饰的明胶可用于生产最终可用于生产三维工程生物构建体的复合材料。 复合材料是改性明胶与至少一种可光化交联的大分子之间的聚合产物。 本文还描述了制备改性明胶的方法。
-
7.发明授权Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof 有权烷基化半合成糖胺聚糖醚，及其制备和使用方法公开(公告)号：US08329673B2
公开(公告)日：2012-12-11
申请号：US13304292
申请日：2011-11-23
IPC分类号： A61K31/728 , A61K9/00 , C08B37/08 , A61P27/02 , A61P27/04
CPC分类号： A61K31/728 , A61K45/06 , C08B37/0072 , C08L5/08 , Y02A50/387
摘要： Described herein are alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated and alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including use for ocular or ophthalmic treatment.
摘要翻译： 本文所述的是烷基化和半合成的糖胺聚糖醚，在本文中称为SAGE。 还描述了硫酸化和烷基化SAGE的合成。 本文所述的化合物可用于许多应用，包括用于眼部或眼部治疗。
-
公开(公告)号：US07981871B2
公开(公告)日：2011-07-19
申请号：US10581571
申请日：2004-12-06
申请人： Glenn D. Prestwich , Xiao Zheng Shu , Yanchun Liu
发明人： Glenn D. Prestwich , Xiao Zheng Shu , Yanchun Liu
IPC分类号： A01N43/04 , A01N25/00 , A61K31/715 , A61K31/727 , A61K47/00 , A61K9/14 , A61K9/50 , C07H5/04 , C07H5/06 , C08B37/00 , C08B37/10
CPC分类号： C08B37/0063 , A61L27/20 , C08B37/0069 , C08B37/0072 , C08B37/0075 , C08H1/06 , C08J3/075 , C08J2305/08 , C08L5/08 , C12N5/0068 , C12N2533/54 , C12N2533/80
摘要： Described herein are compounds such as macromolecules that have been modified in order to facilitate crosslinking by introduction of at least one hydrazide-reactive group and/or aminooxy-reactive group, and methods of making and using thereof for scar-free wound healing, for delivering bioactive agents or living cells, for preventing adhesion after a surgical procedure or for bone and cartilage repair. The macromolecule can be an oligonucleotide, a necleic acid, a polypeptide, a lipid, a glycoprotein, a glycolipid, a polysaccharide, a protein or a synthetic polymer, preferably a glycosaminoglycan like hyaluronan.
摘要翻译： 本文描述的是已经通过引入至少一个酰肼反应性基团和/或氨氧基反应性基团来促进交联而被修饰的化合物，以及制备和使用它们用于无瘢痕伤口愈合的方法，用于递送 生物活性剂或活细胞，用于防止外科手术之后的粘连或用于骨和软骨修复。 大分子可以是寡核苷酸，碳酸，多肽，脂质，糖蛋白，糖脂，多糖，蛋白质或合成聚合物，优选糖胺聚糖如透明质酸。
-
公开(公告)号：US20100330143A1
公开(公告)日：2010-12-30
申请号：US12764466
申请日：2010-04-21
IPC分类号： C07K14/78 , C08B37/00 , C08G63/91 , C08F120/10 , A61K31/728 , A61K38/39 , A61K31/74 , A61F2/00 , B05D5/00 , C12Q1/02 , C12N5/073
CPC分类号： C08B37/0072 , A61K31/728 , A61K31/74 , C08B15/10 , C08B37/003 , C08B37/0045 , C08B37/0069 , C08B37/0075 , C08B37/0084 , C08G63/91 , C08L2203/02 , C12N5/0068 , C12N2533/80 , C12N2537/10
摘要： Described herein are composites produced by reacting a first thiolated macromolecule with at least one compound having at least one thiol-reactive electrophilic functional group. The methods described herein permit the cross-linking of a variety of different thiolated macromolecules with one another. The composites described herein have a variety of biomedical and pharmaceutical applications, which are also described herein.
摘要翻译： 本文描述的是通过使第一硫醇化大分子与至少一种具有至少一个硫醇反应性亲电官能团的化合物反应制备的复合材料。 本文描述的方法允许各种不同硫醇化的大分子彼此交联。 本文描述的复合材料具有各种生物医学和药物应用，其也在本文中描述。
-
公开(公告)号：US5652347A
公开(公告)日：1997-07-29
申请号：US484567
申请日：1995-06-07
申请人： Tara Pouyani , Glenn D. Prestwich
发明人： Tara Pouyani , Glenn D. Prestwich
CPC分类号： C08B37/0072 , Y10S514/944 , Y10S514/95 , Y10S514/964
摘要： Hyaluronate functionalized with dihydrazide is provided and may be cross-linked. A method for producing hyaluronate functionalized with dihydrazide includes mixing hyaluronate and dihydrazide in aqueous solution, then adding carbodiimide so that the hyaluronate and dihydrazide react to form functionalized hyaluronate.
摘要翻译： 提供用二酰肼官能化的透明质酸盐并且可以是交联的。 用二酰肼官能化的透明质酸盐的制备方法包括将透明质酸盐和二酰肼在水溶液中混合，然后加入碳二亚胺使得透明质酸盐和二酰肼反应形成官能化的透明质酸盐。
-
-
-
-
-
-
-
-
-
搜索结果
43 条记录 (耗时 0.039 秒)